S 4327
Securing America’s Drug Supply from Communist China Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:35 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Securing America’s Drug Supply from Communist China Act, aims to strengthen the safety and security of the U.S. drug supply by requiring the Department of Health and Human Services to review pharmaceutical applications from companies based in or affiliated with China. Specifically, it mandates a review process to identify any Chinese entities linked to the Chinese Communist Party or the People’s Liberation Army, and prohibits the approval of new drug applications from such entities. Furthermore, it restricts the import of drugs sponsored by these entities, with provisions for demonstrating compliance or transferring ownership to non-affiliated companies.
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.